Host-bacterial interactions in the initiation of inflammation

Deepa Rastogi, A. J. Ratner, A. Prince

Research output: Contribution to journalArticle

28 Citations (Scopus)

Abstract

The respiratory epithelium provides both a physical and an immunological barrier to inhaled pathogens. In the normal host, innate defences prevent bacteria from activating inflammation by providing efficient muco-ciliary clearance and antimicrobial activity. Bacteria that persist in the airway lumen, as in cystic fibrosis, activate both the professional immune cells in the respiratory mucosa as well as the more abundant airway epithelial cells. As most of the bacteria become entrapped in airway mucin, shed bacterial products such as pili, flagella, peptidoglycan and lipopolysaccharide from lysed bacteria are likely to be the stimuli most important in activating epithelial signalling. The airway cells respond briskly to bacterial components through several signalling systems which activate epithelial expression of pro-inflammatory cytokines and chemokines. These signals recruit neutrophils to the airways where they eliminate the contaminating bacteria causing inflammation and the ensuing clinical signs of infection.

Original languageEnglish (US)
Pages (from-to)245-252
Number of pages8
JournalPaediatric Respiratory Reviews
Volume2
Issue number3
DOIs
StatePublished - 2001
Externally publishedYes

Fingerprint

Inflammation
Bacteria
Respiratory Mucosa
Architectural Accessibility
Flagella
Peptidoglycan
Mucins
Chemokines
Cystic Fibrosis
Lipopolysaccharides
Neutrophils
Epithelial Cells
Cytokines
Infection

Keywords

  • Cystic fibrosis
  • Inflammation
  • P. aeruginosa

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Pulmonary and Respiratory Medicine

Cite this

Host-bacterial interactions in the initiation of inflammation. / Rastogi, Deepa; Ratner, A. J.; Prince, A.

In: Paediatric Respiratory Reviews, Vol. 2, No. 3, 2001, p. 245-252.

Research output: Contribution to journalArticle

Rastogi, Deepa ; Ratner, A. J. ; Prince, A. / Host-bacterial interactions in the initiation of inflammation. In: Paediatric Respiratory Reviews. 2001 ; Vol. 2, No. 3. pp. 245-252.
@article{28d8e080a0ab47c7bd1ab265714d41b4,
title = "Host-bacterial interactions in the initiation of inflammation",
abstract = "The respiratory epithelium provides both a physical and an immunological barrier to inhaled pathogens. In the normal host, innate defences prevent bacteria from activating inflammation by providing efficient muco-ciliary clearance and antimicrobial activity. Bacteria that persist in the airway lumen, as in cystic fibrosis, activate both the professional immune cells in the respiratory mucosa as well as the more abundant airway epithelial cells. As most of the bacteria become entrapped in airway mucin, shed bacterial products such as pili, flagella, peptidoglycan and lipopolysaccharide from lysed bacteria are likely to be the stimuli most important in activating epithelial signalling. The airway cells respond briskly to bacterial components through several signalling systems which activate epithelial expression of pro-inflammatory cytokines and chemokines. These signals recruit neutrophils to the airways where they eliminate the contaminating bacteria causing inflammation and the ensuing clinical signs of infection.",
keywords = "Cystic fibrosis, Inflammation, P. aeruginosa",
author = "Deepa Rastogi and Ratner, {A. J.} and A. Prince",
year = "2001",
doi = "10.1053/prrv.2001.0147",
language = "English (US)",
volume = "2",
pages = "245--252",
journal = "Paediatric Respiratory Reviews",
issn = "1526-0550",
publisher = "W.B. Saunders Ltd",
number = "3",

}

TY - JOUR

T1 - Host-bacterial interactions in the initiation of inflammation

AU - Rastogi, Deepa

AU - Ratner, A. J.

AU - Prince, A.

PY - 2001

Y1 - 2001

N2 - The respiratory epithelium provides both a physical and an immunological barrier to inhaled pathogens. In the normal host, innate defences prevent bacteria from activating inflammation by providing efficient muco-ciliary clearance and antimicrobial activity. Bacteria that persist in the airway lumen, as in cystic fibrosis, activate both the professional immune cells in the respiratory mucosa as well as the more abundant airway epithelial cells. As most of the bacteria become entrapped in airway mucin, shed bacterial products such as pili, flagella, peptidoglycan and lipopolysaccharide from lysed bacteria are likely to be the stimuli most important in activating epithelial signalling. The airway cells respond briskly to bacterial components through several signalling systems which activate epithelial expression of pro-inflammatory cytokines and chemokines. These signals recruit neutrophils to the airways where they eliminate the contaminating bacteria causing inflammation and the ensuing clinical signs of infection.

AB - The respiratory epithelium provides both a physical and an immunological barrier to inhaled pathogens. In the normal host, innate defences prevent bacteria from activating inflammation by providing efficient muco-ciliary clearance and antimicrobial activity. Bacteria that persist in the airway lumen, as in cystic fibrosis, activate both the professional immune cells in the respiratory mucosa as well as the more abundant airway epithelial cells. As most of the bacteria become entrapped in airway mucin, shed bacterial products such as pili, flagella, peptidoglycan and lipopolysaccharide from lysed bacteria are likely to be the stimuli most important in activating epithelial signalling. The airway cells respond briskly to bacterial components through several signalling systems which activate epithelial expression of pro-inflammatory cytokines and chemokines. These signals recruit neutrophils to the airways where they eliminate the contaminating bacteria causing inflammation and the ensuing clinical signs of infection.

KW - Cystic fibrosis

KW - Inflammation

KW - P. aeruginosa

UR - http://www.scopus.com/inward/record.url?scp=0035736038&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035736038&partnerID=8YFLogxK

U2 - 10.1053/prrv.2001.0147

DO - 10.1053/prrv.2001.0147

M3 - Article

C2 - 12052326

AN - SCOPUS:0035736038

VL - 2

SP - 245

EP - 252

JO - Paediatric Respiratory Reviews

JF - Paediatric Respiratory Reviews

SN - 1526-0550

IS - 3

ER -